INTERNATIONAL PATENT: CELECOR THERAPEUTICS, INC. FILES APPLICATION FOR "ZALUNFIBAN FOR USE IN THE TREATMENT OF THROMBOTIC DISORDER IN PATIENTS WITH RENAL IMPAIRMENT"

GENEVA, Jan. 27 -- CELECOR THERAPEUTICS, INC. (1155 Camino Del Mar, Suite 481Del Mar, CA 92014) filed a patent application (PCT/US2025/037663) for "ZALUNFIBAN FOR USE IN THE TREATMENT OF THROMBOTIC DISORDER IN PATIENTS WITH RENAL IMPAIRMENT" on Jul 15, 2025. With publication no. WO/2026/019771, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JOSHI, Yatindra (1205 Meetinghouse RoadNorth Wales, PA 19454), MACARTHUR, Robert (296 Engle St.Tenafly, NJ 07670), DUCHARME, Murray (3630 Bois FrancSt-laurent, QC H4R 3K9)

Abstract: ...